Moreover, the CDK2A locus encoding for p16INK4a is frequently inactivated through deletions, point mutations, or hypermethylation in many malignancies including melanoma, leukemia, pancreatic and head and neck carcinomas, reflecting its established tumor suppressor function [64]. Here, CDKN2A is linked to neoplasm.